NEW YORK (GenomeWeb) – RayBiotech today announced a partnership with XCellCure to develop a cardiovascular disease diagnostic kit.

The firms will co-market and co-distribute the kits worldwide with a focus initially on the research market and the longer term goal of making the technology available to the clinical diagnostics and prognostics spaces.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.